List of insiders holdings for DiaMedica Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| JACINTO RICHARD II 10% Owner | 2023-06-23 17:13:56 | 4,558,823 0 | 4,558,823 | Form 13G |
| Von Koch Thomas TomEnterprise AB TomEqt Private AB 10% Owner | 2023-06-27 16:12:06 | 4,326,435 0 | 4,326,435 | Form 13G |
| STAHLBERG JAN TRILL AB 10% Owner | 2023-06-27 16:11:32 | 4,021,608 0 | 4,021,608 | Form 13G |
| Xiao Zhenyu Hermeda Industrial Co. Ltd Director 10% Owner | 2020-12-23 16:31:17 | 936,805 0 | 936,805 | Form 13G |
| Xiao Zhenyu Director | 2020-12-23 16:31:17 | 936,805 0 | 936,805 | Form 13G |
| Wambeke David J. Chief Business Officer | 2023-11-16 16:37:28 | 527,114 0 | 527,114 | Form 4 |
| Giuffre Randall Michael Director | 2024-01-02 16:30:43 | 364,551 46,643 | 411,194 | Form 4 |
| Lorianne Masuoka K. Chief Medical Officer | 2024-01-23 16:23:11 | 285,000 0 | 285,000 | Form 4 |
| Pilnik Richard D. Director | 2024-01-02 16:47:45 | 278,602 0 | 278,602 | Form 4 |
| Burroughs Amy L. Director | 2023-01-03 16:36:27 | 73,288 0 | 73,288 | Form 4 |
| Verdoorn Todd A. Chief Scientific Officer | 2019-06-26 16:54:07 | 73,025 0 | 73,025 | Form 4 |
| Pauls Dietrich John President and CEO | 2023-06-26 16:34:35 | 68,591 0 | 68,591 | Form 4 |
| Gruis Kirsten L Chief Medical Officer | 2023-06-02 16:55:43 | 67,000 0 | 67,000 | Form 4 |
| Parsons James T. Director | 2024-01-02 16:39:36 | 59,937 0 | 59,937 | Form 4 |
| Daves Julie VanOrsdel SVP Clinical Development Oper. | 2023-06-02 17:16:33 | 54,000 0 | 54,000 | Form 4 |
| ALCORN HARRY W JR SVP, Clinical Operations | 2021-09-15 16:37:42 | 43,582 399 | 43,981 | Form 4 |
| Semba Charles Pauling Director | 2024-01-02 17:05:18 | 39,318 0 | 39,318 | Form 4 |
| Kellen Scott CFO and Secretary | 2023-06-26 16:21:11 | 32,290 0 | 32,290 | Form 4 |
| Cundari Dominic R Chief Commercial Officer | 2023-06-02 17:01:05 | 29,800 0 | 29,800 | Form 4 |
| Gilman Sydney A. VP, Regulatory Affairs | 2021-07-29 21:18:27 | 25,000 0 | 25,000 | Form 4 |
| Kuntz Richard Director | 2024-01-02 17:00:26 | 14,285 0 | 14,285 | Form 4 |
| Lewis Tanya Director | 2023-06-02 16:13:39 | 7493 0 | 7493 | Form 4 |